SFC

CARDIOLOGIE PEDIATRIQUE

  • Cardiac tomography-echocardiography imaging fusion: a new approach to congenital heart disease [REV ESP CARDIOL]
  • Familial Recurrence Patterns in Congenitally Corrected Transposition of the Great Arteries: An International Study [AHA JOURNALS]
  • Multifactorial pulmonary hypertension in infantile scimitar syndrome [SCIENCE DIRECT]

CARDIO-ONCOLOGIE

  • Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program. Journal of clinical oncology, JCO2200369. Advance online publication. [DOI]
  • Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis. Circulation, 101161CIRCULATIONAHA121056730. Advance online publication. [DOI]
  • Cardiovascular Disease Risk Among Cancer Survivors. J Am Coll Cardiol. 2022 Jul, 80 (1) 22–32. [DOI]
  • Cardiometabolic Comorbidities in Cancer Survivors. J Am Coll Cardiol CardioOnc. 2022 Jun, 4 (2) 149-165. [DOI]
  • Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity. Circulation. Heart failure, 101161CIRCHEARTFAILURE121009445. Advance online publication. [DOI]
  • Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies. J Am Coll Cardiol CardioOnc. 2022 Jun, 4 (2) 223- 234. [DOI]

CORONAIRES ET INTERVENTIONNEL

  • Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) [ACADEMIC]
  • P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications [ACADEMIC]
  • Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events [AHA JOURNALS]
  • For Best Results in ACS PCI: Treat Upstream With P2Y12 Inhibitors [ACC]

HTA

  • Hypertensive Disorders in Pregnancy Are on the Rise [JAMA NETWORK]
  • Review of Long-Term Blood Pressure Control After Intracerebral Hemorrhage: Challenges and Opportunities [AHA JOURNALS]

IMAGERIE CARDIOVASCULAIRE

  • Age Alters Prevalence of Left Atrial Enlargement and Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source [AHA JOURNALS]
  • Transesophageal Echocardiography Following Left Atrial Appendage Electrical Isolation: Diagnostic Pitfalls and Clinical Implications [AHA JOURNALS]

INSUFFISANCE CARDIAQUE – CARDIOMYOPATHIES

  • Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes [AHA JOURNALS]

RISQUE CARDIOVASCULAIRE

  • Effects of Coronary Artery Disease–Associated Variants on Vascular Smooth Muscle Cells [AHA JOURNALS]
  • Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function [JAMA NETWORK]
  • Sitting Time and Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries [JAMA NETWORK]
  • Mediterranean Diet vs Low-fat Diet for Patients With Heart Disease [JAMA NETWORK]

RYTHMOLOGIE

  • Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial [AHA JOURNALS]
  • Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice? [ACADEMIC]
  • Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy [NCBI NLM NIH]
  • Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass [ACADEMIC]
  • Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial [AHA JOURNALS]

USIC

  • Drug Interactions Affecting Oral Anticoagulant Use [NCBI NLM NIH]

VALVULOPATHIES

  • Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement [JAMA NETWORK]

COVID

  • Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants [NEJM]
  • Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy [NEJM]
  • Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 [NEJM]

LA FRANCE A L’HONNEUR

  • Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events [AHA JOURNALS]
  • Impact of Age on Systemic Inflammatory Profile of Patients With ST-Segment–Elevation Myocardial Infarction and Acute Ischemic Stroke [AHA JOURNALS]

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !